Plain-English translation of NCT07532486 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Psoriasis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing , a medication that helps treat moderate-to-severe plaque psoriasis (a skin condition causing thick, scaly patches). The study compares two different ways of giving the medication: a higher dose given less often, versus a standard dose given more frequently. Researchers want to see if the less-frequent, higher-dose approach works just as well as the standard approach while being easier for patients to manage.
Many patients struggle with frequent doctor visits and injections for psoriasis treatment. This medication works well, but researchers want to find out if they can reduce the treatment burden by using a higher dose less often, making it more convenient without sacrificing effectiveness.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive injections of the medication at different time points over about 2 years. You'll be randomly assigned to receive either the higher dose less frequently or the standard dose more regularly. Throughout the study, you'll have regular clinic visits where doctors will check your skin, take blood samples, ask about side effects, and assess how well the medication is working using standard psoriasis rating scales. The entire study lasts about 2 years, with a screening period, an active treatment phase, and a follow-up period.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
China